The forecast for the import of antisera and other blood fractions to Japan from 2024 to 2028 shows a consistent upward trend, starting from 7.13 billion USD in 2024 and rising to 8.01 billion USD by 2028. This represents a steady annual growth rate, indicating a healthy demand for these medical products. Comparatively, in 2023, Japan imported a significantly lower volume, marking the beginning of this upward trend.

Key future trends to watch for include:

Advancements in medical research and technology potentially increasing demand for blood fractions.
Regulatory changes that may impact import processes or costs in Japan.
Global health trends and events that could influence import volumes, such as pandemics or emerging diseases.